2002
DOI: 10.1073/pnas.152313999
|View full text |Cite|
|
Sign up to set email alerts
|

Interaction of intracellular β amyloid peptide with chaperone proteins

Abstract: Expression of the human β amyloid peptide (Aβ) in transgenic Caenorhabditis elegans animals can lead to the formation of intracellular immunoreactive deposits as well as the formation of intracellular amyloid. We have used this model to identify proteins that interact with intracellular Aβ in vivo . Mass spectrometry analysis of proteins that specifically coimmunoprecipitate with Aβ has identified six likely chaperone proteins: two members of the HSP70 family, th… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

12
151
1
1

Year Published

2004
2004
2013
2013

Publication Types

Select...
6
2
1

Relationship

1
8

Authors

Journals

citations
Cited by 196 publications
(165 citation statements)
references
References 51 publications
12
151
1
1
Order By: Relevance
“…aip-1(RNAi) accelerated the mean onset of paralysis from 11.3 Ϯ 0.2 days in mock RNAi to 7.6 Ϯ 0.2 days in aip-1(RNAi) animals. A similar effect was observed in hsf-1(RNAi) (mean onset of paralysis, 7.5 Ϯ 0.2 days) (20) (Fig. 2C).…”
Section: Worm Aip-1 Is Required For Normal Lifespan and Resistance Tosupporting
confidence: 81%
“…aip-1(RNAi) accelerated the mean onset of paralysis from 11.3 Ϯ 0.2 days in mock RNAi to 7.6 Ϯ 0.2 days in aip-1(RNAi) animals. A similar effect was observed in hsf-1(RNAi) (mean onset of paralysis, 7.5 Ϯ 0.2 days) (20) (Fig. 2C).…”
Section: Worm Aip-1 Is Required For Normal Lifespan and Resistance Tosupporting
confidence: 81%
“…Furthermore, the Hsp16 proteins co-localized and coimmunoprecipitated with Aβ(1-42) in this model [89] and increased expression of Hsp16 partially suppressed the Aβ-mediated toxicity [90]. It was concluded that sHsps such as Hsp16 may act to reduce Aβ toxicity by interacting directly with the Aβ peptide and altering its oligomerization pathways, thereby reducing the formation of some toxic species [90].…”
Section: Shsps and Alzheimer's Diseasementioning
confidence: 87%
“…In a series of elegant papers using transgenic Caenorhabditis elegans worms, the expression of human Aβ(1-42) was found to lead to the induction of Hsp16 proteins (sHsps that are homologs of αB-crystallin in vertebrates) [89]. Furthermore, the Hsp16 proteins co-localized and coimmunoprecipitated with Aβ(1-42) in this model [89] and increased expression of Hsp16 partially suppressed the Aβ-mediated toxicity [90].…”
Section: Shsps and Alzheimer's Diseasementioning
confidence: 99%
“…In a Caenorhabditis elegans model for Alzheimer disease, SGT was found to be present in protein complexes including b-amyloid peptide, several chaperones and chaperone-like protein. Furthermore, when SGT was knockdown by dsRNA, the toxic effect of exogenous expression of b-amyloid peptide was significantly reduced, implying that SGT may be involved in b-amyloid peptide-dependent pathogenicity in this model system [10]. On the other hand, rat SGT promoted the chaperone activity of Hsc70 in a tripartite complex containing the cysteine string protein (Csp) and Hsc70, which is thought to participate in vesicle-mediated neuronal signal transduction [11].…”
Section: Introductionmentioning
confidence: 93%